Odyliresin

Iresine celosia · Fondazione IRCCS Policlinico San Matteo di Pavia

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Odyliresin, covering 2017-02-28 to 2017-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia [NA]